Previous 10 | Next 10 |
Apollo Endosurgery, Inc. (APEN) Q4 2021 Earnings Conference Call February 22, 2022, 4:30 PM ET Company Participants Charles McKhann – Chief Executive Officer Jeff Black – Chief Financial Officer Matt Kreps – Investor Relations Conference Call Participants Eric Assaraf ...
Apollo Endosurgery press release (NASDAQ:APEN): Q4 GAAP EPS of -$0.27 misses by $0.09. Revenue of $16.2M (+26.0% Y/Y) in-line. For further details see: Apollo Endosurgery GAAP EPS of -$0.27 misses by $0.09, revenue of $16.2M in-line
Increased adoption across all product lines in both U.S. and international Grew fourth quarter 2021 revenue 26% AUSTIN, TX / ACCESSWIRE / February 22, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal a...
A, ACC, ADC, AGR, APEN, API, APLE, AROC, AWR, AXGN, BCC, BLKB, BNL, BRFS, BRY, BTG, BWXT, BXC, CDNS, CERS, CGBD, CSGP, CUTR, CWH, CZR, EPR, EXAS, FANG, FPI, GKOS, GMBL, GTE, HALO, HCC, HIMS, HTGC, INDI, KTOS, LAND, LILA, LPI, MAXR, MELI, MOS, MTDR, NDSN, NHI, NU, O, OMAB, PANW, PEB, PEN, OTCP...
AUSTIN, TX / ACCESSWIRE / February 10, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release financia...
Fourth quarter 2021 revenue grew 25% over 2020 AUSTIN, TX / ACCESSWIRE / January 10, 2022 / Apollo Endosurgery, Inc. ("Apollo" or the "Company") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced preliminary u...
$35 million funded at close to refinance existing debt, extend maturity and lower interest expense Additional borrowing capacity provides minimally dilutive growth capital and strategic flexibility AUSTIN, TX / ACCESSWIRE / December 21, 2021 / Apollo Endosurgery, Inc. ("Apollo"...
The following slide deck was published by Apollo Endosurgery, Inc. in conjunction with this event. For further details see: Apollo Endosurgery (APEN) Presents At 2021 Virtual Healthcare Conference - Slideshow
Apollo Endosurgery Inc. (NASDAQ:APEN) traded at a new 52-week high today of $10.35. This new high was reached on below average trading volume as 106,000 shares traded hands, while the average 30-day volume is approximately 277,000 shares. In the past 52 weeks, Apollo Endosurgery Inc. sha...
AUSTIN, TX / ACCESSWIRE / November 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that management will participate in four upcoming investor conference events. ...
News, Short Squeeze, Breakout and More Instantly...
Apollo Endosurgery Inc. Company Name:
APEN Stock Symbol:
NASDAQ Market:
Apollo Endosurgery Inc. Website:
NEW YORK, NY / ACCESSWIRE / February 1, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Apollo Endosurgery, Inc. (NASDAQ:APEN...
NEW YORK, NY / ACCESSWIRE / January 8, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: KnowBe4, Inc. (NASDAQ:KNBE)'s sale t...
MERIT Trial Selected as 2022 Top Story in Gastroenterology and ASMBS adds Apollo Systems to List of Approved Bariatric Devices AUSTIN, TX / ACCESSWIRE / December 13, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointe...